Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists

被引：14

作者：

Pettersson, Martin ^{[1
]}

Campbell, Brian M. ^{[1
]}

Dounay, Amy B. ^{[1
]}

Gray, David L. ^{[1
]}

Xie, Longfei ^{[1
]}

O'Donnell, Christopher J. ^{[1
]}

Stratman, Nancy C. ^{[1
]}

Zoski, Kim ^{[1
]}

Drummond, Elena ^{[1
]}

Bora, Gary ^{[1
]}

Probert, Al ^{[1
]}

Whisman, Tammy ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Groton, CT 06340 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 02期

关键词：

Norepinephrine reuptake inhibitor; 5-HT1A agonist; NRI; NET; DAT; SERT; ADHD; Depression; EFFICACY; REBOXETINE;

D O I：

10.1016/j.bmcl.2010.11.066

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Compounds with combined norepinephrine reuptake inhibitor (NRI) and serotonin 1A (5-HT1A) partial agonist pharmacology may offer a new therapeutic approach for treating symptoms of neuropsychiatric disorders including ADHD, depression, and anxiety. Herein we describe the design and optimization of novel chemical matter that exhibits favorable dual NRI and 5-HT1A partial agonist activity. Lead compounds in this series were found to be devoid of activity at the dopamine transporter and were shown to be brain penetrant with high receptor occupancy. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：865 / 868

页数：4

共 50 条

[1] Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists
Dounay, Amy B.
Barta, Nancy S.
Campbell, Brian M.
Coleman, Corey
Collantes, Elizabeth M.
Denny, Lynne
Dutta, Satavisha
Gray, David L.
Hou, Dongfeng
Iyer, Rathna
Maiti, Samarendra N.
Ortwine, Daniel F.
Probert, Al
Stratman, Nancy C.
Subedi, Rajendra
Whisman, Tammy
Xu, Wenjian
Zoski, Kim
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1114 - 1117
[2] Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists
Gary, David L.
Xu, Wenjian
Campbell, Brian M.
Dounay, Amy B.
Barta, Nancy
Boroski, Susan
Denny, Lynne
Evans, Lori
Stratman, Nancy
Probert, Al
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6604 - 6607
[3] Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists
Dounay, Amy B.
Barta, Nancy S.
Bikker, Jack A.
Borosky, Susan A.
Campbell, Brian M.
Crawford, Terry
Denny, Lynne
Evans, Lori M.
Gray, David L.
Lee, Pil
Lenoir, Edward A.
Xu, Wenjian
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (04) : 1159 - 1163
[4] Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
Wen, Hui
Qin, Wen
Yang, Guangzhong
Guo, Yanshen
MOLECULES, 2019, 24 (03)
[5] Synthesis and structure-activity relationship in a class of indolebutylpiperazines as dual 5-HT1A receptor agonists and serotonin reuptake inhibitors
Heinrich, T
Böttcher, H
Gericke, R
Bartoszyk, GD
Anzali, S
Seyfried, CA
Greiner, HE
van Amsterdam, C
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (19) : 4684 - 4692
[6] Clarifications on the effects of 5-HT1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system
Blier, P
deMontigny, C
NEUROPSYCHOPHARMACOLOGY, 1996, 15 (02) : 213 - 214
[7] Clarifications on the effects of 5-HT1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system - Response
Albert, PR
Storring, JM
NEUROPSYCHOPHARMACOLOGY, 1996, 15 (02) : 215 - 216
[8] 5-HT1A partial agonists as anxiolytics and antidepressants
Sprouse, J
JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S35 - S35
[9] 5-HT1A PARTIAL AGONISTS - WHAT IS THEIR FUTURE
GLITZ, DA
POHL, R
DRUGS, 1991, 41 (01) : 11 - 18
[10] 5-HT1A partial agonists as anxiolytics and antidepressants
Sprouse, J
NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, : 47 - 53

← 1 2 3 4 5 →